Empirical Radioactive Iodine Therapy in DTC
ConditionDifferentiated Thyroid Cancer
Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
The aim of the study is assessment the efficacy of empiric RAI therapy in DTC patients with elevated thyroglobulin levels and negative iodine scintigraphy.
Eligibility criteria
Qualifiers
This study will include adult patients with pathologically proved DTC who underwent total thyroidectomy and received RAI therapy presented to our nuclear medicine unit with evidence of persistent or recurrent biochemical disease during follow up.
Disqualifiers
Undifferentiated thyroid cancer.
Patients with evidence of structural disease.
Patients less than 18 years old.
Trial design
Treatments tested in this trial
- Radioactive Iodine Therapy
Treatment groups
100 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov